Clinical Trial Update: Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHD [Phase 2]

View source ↗

Summary

Phase 2 trial update on first-line therapy for acute graft-versus-host disease using a combination of steroids and a humanized anti-CD25 monoclonal antibody; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Humanized CD25 monoclonal antibody (anti-CD25 monoclonal antibody)
• Steroid (steroid)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acute Graft Versus Host Disease | Phase 2 | Status: NOT_YET_RECRUITING